Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Investing

Pfizer : PFE

All Pfizer Articles

1508 Articles

Michael Williams | May 24, 2026 at 2:00 PM EDT

Why Retirees Keep Buying This Dividend ETF After 22 Years of Payments

iShares Select Dividend ETF (NASDAQ:DVY) is one of the older income-focused funds on the market. The question for owners is…

Alex Sirois | May 19, 2026 at 12:38 PM EDT

The SoFi CEO Just Bought 70,000 Shares With His Own Money. Here Are Four More Under $30 Worth a Closer Look

With markets at elevated multiples in May 2026, low share prices can mislead investors into thinking quality is out of…

David Moadel | May 19, 2026 at 12:15 PM EDT

Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn’t a Slam Dunk

BridgeBio Pharma (NASDAQ:BBIO | BBIO Price Prediction) received a Neutral initiation from Citi Neutral on Tuesday, reflecting a measured stance…

Alex Sirois | May 19, 2026 at 10:46 AM EDT

Rate Cuts Are Off the Table. Here Are 2 Stocks Under $30 Built Exactly for This Moment

With short-term rates still elevated, tariff uncertainty churning through earnings models, and credit spreads widening at the margins, balance sheet…

Austin Smith | May 16, 2026 at 6:00 AM EDT

GRNY Beat COWZ by 11 Points This Year. Oil Prices and Interest Rates Will Decide Who Wins Next

The Pacer US Cash Cows 100 ETF (NYSEARCA:COWZ) and the Fundstrat Granny Shots US Large Cap ETF (NYSEARCA:GRNY) sit on…

Alex Sirois | May 15, 2026 at 9:49 AM EDT

Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why

Pfizer (NYSE:PFE | PFE Price Prediction) at $25.75, Molina Healthcare (NYSE:MOH) at $186.80, and Halliburton (NYSE:HAL) at $41.29 trade at…

Alex Sirois | May 12, 2026 at 9:34 AM EDT

3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy

Warren Buffett built Berkshire Hathaway by paying reasonable prices for durable cash flows, and three of his current bets still…

David Moadel | May 11, 2026 at 10:53 AM EDT

Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near $57.52…

Trey Thoelcke | May 11, 2026 at 9:05 AM EDT

Pfizer vs Eli Lilly: Different Bets on Pharma M&A

Pfizer (NYSE: PFE | PFE Price Prediction) and Eli Lilly (NYSE: LLY) recently reported quarterly results that read like two…

Vandita Jadeja | May 6, 2026 at 10:32 AM EDT

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash

Dividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities remain the cleanest…

Gerelyn Terzo | May 5, 2026 at 10:11 AM EDT

Alphabet, Intel, Micron Lead Nasdaq Higher as Oil Drops on Paused Mideast Tensions

The Nasdaq Composite (^IXIC) opened higher Tuesday, with the tech-heavy benchmark riding a familiar trio of tailwinds: a fresh wave…

Ian Cooper | May 5, 2026 at 8:47 AM EDT

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

The rollercoaster ride continues.After a rough start to the week on war concerns and higher oil prices, the major indices…

Vandita Jadeja | May 4, 2026 at 10:09 AM EDT

Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era

Pfizer (NYSE:PFE | PFE Price Prediction) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is…

Lee Jackson | May 1, 2026 at 7:43 AM EDT

5 Quality Passive Income Blue-Chips That All Yield 5% and More Safely

Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable performance history. They are often…

Ian Cooper | Apr 27, 2026 at 9:05 AM EDT

Want $1,188 in Passive Income? Invest $5,000 Into These 3 High-Yielding Stocks

Wages cover the bills. Dividends buy back your time. Earned income stops when you do; portfolio income deposits into your…

1 2 3 4 5 … 101

Pfizer : PFE

All Pfizer Articles

Why Retirees Keep Buying This Dividend ETF After 22 Years of Payments

The SoFi CEO Just Bought 70,000 Shares With His Own Money. Here Are Four More Under $30 Worth a Closer Look

Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn’t a Slam Dunk

Rate Cuts Are Off the Table. Here Are 2 Stocks Under $30 Built Exactly for This Moment

GRNY Beat COWZ by 11 Points This Year. Oil Prices and Interest Rates Will Decide Who Wins Next

Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why

3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy

Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Pfizer vs Eli Lilly: Different Bets on Pharma M&A

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash

Alphabet, Intel, Micron Lead Nasdaq Higher as Oil Drops on Paused Mideast Tensions

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era

5 Quality Passive Income Blue-Chips That All Yield 5% and More Safely

Want $1,188 in Passive Income? Invest $5,000 Into These 3 High-Yielding Stocks

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Defense Investor: 300 Companies Could Define the Future of Warfare – and 92 of Them Are International. “Instead of Thinking U.S. Hegemony, Now We’re Thinking This Is an Allied Play”

Intel’s $200 Billion Turnaround Plan Is Under the Microscope

73-Year-Old With $1.8M Faces $80,000 RMD That Pushes Him Into the Top Tax Bracket

73-Year-Old With $1.8M Faces $80,000 RMD That Pushes Him Into the Top Tax Bracket

Consumer Credit Plunges By Most in Almost 6 Years. There Could Be a Terrifying Reason Why

Defense Investor: 300 Companies Could Define the Future of Warfare – and 92 of Them Are International. “Instead of Thinking U.S. Hegemony, Now We’re Thinking This Is an Allied Play”

Intel’s $200 Billion Turnaround Plan Is Under the Microscope

Pfizer : PFE

All Pfizer Articles

Why Retirees Keep Buying This Dividend ETF After 22 Years of Payments

The SoFi CEO Just Bought 70,000 Shares With His Own Money. Here Are Four More Under $30 Worth a Closer Look

Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn’t a Slam Dunk

Rate Cuts Are Off the Table. Here Are 2 Stocks Under $30 Built Exactly for This Moment

GRNY Beat COWZ by 11 Points This Year. Oil Prices and Interest Rates Will Decide Who Wins Next

Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why

3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy

Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Pfizer vs Eli Lilly: Different Bets on Pharma M&A

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash

Alphabet, Intel, Micron Lead Nasdaq Higher as Oil Drops on Paused Mideast Tensions

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era

5 Quality Passive Income Blue-Chips That All Yield 5% and More Safely

Want $1,188 in Passive Income? Invest $5,000 Into These 3 High-Yielding Stocks

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Defense Investor: 300 Companies Could Define the Future of Warfare – and 92 of Them Are International. “Instead of Thinking U.S. Hegemony, Now We’re Thinking This Is an Allied Play”

Intel’s $200 Billion Turnaround Plan Is Under the Microscope

73-Year-Old With $1.8M Faces $80,000 RMD That Pushes Him Into the Top Tax Bracket

Featured Reads

73-Year-Old With $1.8M Faces $80,000 RMD That Pushes Him Into the Top Tax Bracket

Consumer Credit Plunges By Most in Almost 6 Years. There Could Be a Terrifying Reason Why